Isolation and characterisation of an anticryptococcal protein in human cerebrospinal fluid

Journal of Medical Microbiology

Volumn 50, Issue 1, 2001, Pages 83-89

  Ahluwalia, M ^a   Brummer, E ^a   Sridhar, S ^a   Singh, R ^a   Stevens, D A ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIETHYLAMINOETHANOL; ALBUMIN; ANTICRYPTOCOCCAL PROTEIN; PROTEIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANION EXCHANGE; ANTIFUNGAL ACTIVITY; ARTICLE; ASSAY; CEREBROSPINAL FLUID; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DEFENSE MECHANISM; FRACTIONATION; FUNGUS GROWTH; GROWTH INHIBITION; HUMAN; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN TRANSPORT;

EID: 0035172865     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-50-1-83     Document Type: Article

References (10)

1. Cryptococcal infections in patients with acquired immune deficiency syndrome
2. Overview: Cryptococcosis in the patient with AIDS
3. Antifungal activity of cerebrospinal fluid against Cryptococcus neoformans and Candida species
4. Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity
5. Brain iron homeostasis
6. Ferric iron reduction by Cryptococcus neoformans
7. Ferrous iron uptake in Cryptococcus neoformans
8. Molecular biology of iron acquisition in Saccharomyces cerevisiae
9. A mutation in ceruloplasmin gene is associated with systemic hemosiderosis in humans